Eliem Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 4%.

Top 25 shareholders own 96.36% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
46.9%	RA Capital Management, L.P.	13,150,849	US$60.0m	0%	0.74%
17.9%	Ai Eti Llc	5,009,400	US$22.8m	0%	no data
7.77%	BML Capital Management, LLC	2,180,000	US$9.9m	12.5%	6.37%
7.14%	Intermediate Capital Group plc	2,002,563	US$9.1m	0%	100.0%
5.21%	LifeArc, Endowment Arm	1,461,538	US$6.7m	0%	no data
3%	Farringdon Capital Management	841,087	US$3.8m	0%	2.77%
2.89%	Driehaus Capital Management LLC	811,680	US$3.7m	0%	0.03%
1.8%	Valerie Morisset	505,307	US$2.3m	3.66%	no data
1.11%	The Vanguard Group, Inc.	310,486	US$1.4m	0.21%	no data
0.64%	Adam Rosenberg	178,100	US$812.1k	0%	no data
0.61%	Braden Leonard	170,682	US$778.3k	135%	no data
0.28%	Atom Investors LP	78,276	US$356.9k	-0.77%	0.06%
0.24%	Geode Capital Management, LLC	66,626	US$303.8k	0%	no data
0.2%	Bridgeway Capital Management, LLC	55,223	US$251.8k	0%	no data
0.17%	Northern Trust Global Investments	48,712	US$222.1k	336%	no data
0.11%	BlackRock, Inc.	31,145	US$142.0k	-0.53%	no data
0.11%	Tudor Investment Corporation	29,490	US$134.5k	-0.72%	no data
0.077%	State Street Global Advisors, Inc.	21,700	US$99.0k	0%	no data
0.066%	Millennium Management LLC	18,423	US$84.0k	-68.4%	no data
0.049%	Cerity Partners LLC	13,821	US$63.0k	0%	no data
0.043%	Chicago Partners Investment Group LLC	12,160	US$55.4k	-5.04%	no data
0.038%	Renaissance Technologies LLC	10,603	US$48.4k	0%	no data
0.03%	Woodbury Financial Services, Inc, Securities Investments	8,333	US$38.0k	0%	no data
0.012%	Tower Research Capital LLC	3,455	US$15.8k	-11.3%	no data
0.0061%	Morgan Stanley Investment Management Inc.	1,709	US$7.8k	0%	no data